# PhaseBio Pharmaceuticals Inc — Form D/A

PhaseBio Pharmaceuticals Inc of Malvern, PA, a company, filed a Form D amendment with the SEC on 2015-07-21. The offering totals $42.0M, of which $21.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-07-21
- Form: D/A
- Accession: 0001169245-15-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $42.0M
- Amount sold: $21.0M
- Remaining: $21.0M
- Investors: 9
- Date of first sale: 2015-02-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-235733

## Issuer

- Name: PhaseBio Pharmaceuticals Inc
- CIK: 0001169245
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: One Great Valley Parkway, Malvern, PA, 19355
- Phone: (610) 981-6500

## Officers, directors & promoters (28)

_Showing 25 of 28 people._

| Name | Role | Location |
| --- | --- | --- |
| Joel Sussman | Executive Officer | Malvern, PA |
| Clay Thorp | Director | Durham, NC |
| Ashutosh Chilkoti | Director | Durham, NC |
| Ashutosh Chilkoti | Executive Officer | Durham, NC |
| Jonathan Mow | Director | El Cajon, CA |
| Jonathan Mow | Executive Officer | El Cajon, CA |
| Tyrell Rivers | Director | Chicago, IL |
| Justin Klein | Director | San Carlos, CA |
| Linda Tufts | Director | Cleveland, OH |
| Christopher Prior | Director | Raleigh, NC |
| Christopher Prior | Executive Officer | Raleigh, NC |
| Bibhash Mukhopadhyay | Director | Malvern, PA |
| John Sharp | Executive Officer | Malvern, PA |
| Nancy Hutson | Director | Malvern, PA |
| Caroline Loewy | Director | Malvern, PA |
| Michael K Gutch | Director | Research Triangle Park, NC |
| Thomas K Laundon | Director | Research Triangle Park, NC |
| Thomas K Laundon | Executive Officer | Research Triangle Park, NC |
| Douglas K Reed | Director | Durham, NC |
| Craig K Rosen | Director | Pasadena, MD |
| Justin K Klein | Director | Chevy Chase, MD |
| Guy K Fish | Director | Boston, MA |
| Asish K Xavier | Director | New Brunswick, NJ |
| James K Barrett | Director | Baltimore, MD |
| Robert K Ingram | Director | Durham, NC |

## Other filings by this issuer (7)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2018-09-10](https://search.stillhousedata.com/formd/0001169245-18-000001) | D | $32.1M | $26.0M |
| [2017-01-31](https://search.stillhousedata.com/formd/0001169245-17-000002) | D | $7.9M | $6.6M |
| [2015-03-12](https://search.stillhousedata.com/formd/0001169245-15-000001) | D | $40.0M | $20.0M |
| [2012-06-18](https://search.stillhousedata.com/formd/0001169245-12-000001) | D/A | $48.5M | $48.5M |
| [2010-12-06](https://search.stillhousedata.com/formd/0001169245-10-000002) | D/A | $25.3M | $25.3M |
| [2010-01-05](https://search.stillhousedata.com/formd/0001169245-10-000001) | D | $25.3M | $10.1M |
| [2009-11-12](https://search.stillhousedata.com/formd/0001169245-09-000004) | D | $1.0M | $1000K |

## More

- [CIK 1169245 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1169245&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001169245-15-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.